Business Model
There are hundreds of promising drugs that require further development, financing and management to unleash their potential and become successful products.
Our proven regulatory expertise, clinical study expertise and ability to raise capital allows YM BioSciences to advance high-potential products effectively and with reduced risk, via a diversified portfolio model and licensing philosophy, toward international approval, marketing and commercialization.